Please use this identifier to cite or link to this item:
|Title:||Technology behind commercial devices for blood glucose monitoring in diabetes management: A review|
|Keywords:||Blood glucose monitoring devices|
Glucose limiting membranes
|Citation:||Vashist, S.K., Zheng, D., Al-Rubeaan, K., Luong, J.H.T., Sheu, F.-S. (2011-10-10). Technology behind commercial devices for blood glucose monitoring in diabetes management: A review. Analytica Chimica Acta 703 (2) : 124-136. ScholarBank@NUS Repository. https://doi.org/10.1016/j.aca.2011.07.024|
|Abstract:||The blood glucose monitoring devices (BGMDs) are an integral part of diabetes management now-a-days. They have evolved tremendously within the last four decades in terms of miniaturization, rapid response, greater specificity, simplicity, minute sample requirement, painless sample uptake, sophisticated software and data management. This article aims to review the developments in the technologies behind commercial BGMD, especially those in the areas of chemistries, mediators and other components. The technology concerns, on-going developments and future trends in blood glucose monitoring (BGM) are also discussed. © 2011 Elsevier B.V.|
|Source Title:||Analytica Chimica Acta|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Sep 19, 2018
WEB OF SCIENCETM
checked on Sep 5, 2018
checked on Aug 17, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.